NEW YORK (360Dx) – Value-Dx, a European project aimed at tackling antimicrobial resistance spearheaded by six in vitro diagnostic firms and 20 non-industry partners, was launched this week.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.